The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments in gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.
The safety of gadolinium-based contrast agents for MRI continues to generate much controversy and discussion. As both a radiologist and a lawyer, Dr. Alexander Radbruch, JD, is well-placed to comment on the most significant recent developments on gadolinium retention in the brain, how best to use these agents, and how radiologists and manufacturers can help to avoid being sued.Video from ECR 2019: Alexander Radbruch on gadolinium debate
Feb 28, 2019
Latest in PACS/VNA
Synthesis Health wins new contracts
June 14, 2024
InsiteOne acquires Brit Systems
November 30, 2023
What are the benefits of using an AI server downstream of PACS?
November 28, 2023